No immediate trading implications. Traders should monitor for any unexpected disclosures during or after the AGM, though such events are typically routine for clinical-stage biotechs like Evaxion.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 19 $4.00entry
- T+1 · 8mo ago −2.25%α −0.51% · $3.91
- T+5 · 8mo ago −10.25%α −8.04% · $3.59
- T+20 · 7mo ago +11.25%α +3.63% · $4.45
- T+60 · 5mo ago −10.00%α −24.34% · $3.60
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Evaxion announced the convening of its Annual General Meeting on April 16, 2026, to be held at its headquarters in Denmark. The filing contains no material financial updates or operational developments, only administrative details about the meeting.
Key Facts
- Annual General Meeting scheduled for April 16, 2026, at 14:00 CET
- Meeting to be held at Evaxion's offices in Hørsholm, Denmark
- Agenda and proposals available on the company’s investor relations website
- No financial results, guidance, or material corporate updates disclosed
Financial Impact
No financial impact disclosed
Risk Factors
- Lack of near-term catalysts; company remains in clinical development with no commercial revenue
- Forward-looking statements highlight risks around funding, clinical trial success, and market acceptance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3259026 |
Track record
50 reports on EVAX
7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +22.94% at T+5 after the Mar 5, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
- Nov 12, 20264d ago Press Release Neutral 1/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
- Nov 9, 20267d ago 6-K / F-1/A / PRESS-RELEASE Neutral 3/10 Entry $2.75 to $2.86 Now $2.77 +0.73% ▲ +4.00% +4.37% vs SPY
- Nov 6, 202610d ago 6-K Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
- Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
- Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
- Nov 3, 202613d ago 6-K Neutral 4/10 Entry $2.96 to $2.97 Now $2.77 −6.42% ▲ +0.34% −1.31% vs SPY
- Oct 30, 202617d ago 6-K Neutral 2/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
- Oct 30, 202617d ago Press Release Neutral 3/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers